Bringing innovative TMS therapy and patient-centered psychiatric care to improve depression and anxiety outcomes in ...
Want to learn more about the cutting-edge science of metabolic psychiatry? This webinar will explore metabolic therapies for ...
As U.S. policies increasingly promote involuntary psychiatric commitment for homeless populations following a July 2025 ...
Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.
As geopolitical tensions ratchet up around the world, the European Psychiatric Association (EPA) has launched an initiative ...
GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness absence due to psychiatric reasons, a new study shows.
A new analysis represents the largest effort yet to systematically parse all the data from high-quality clinical trials on cannabis and mental health. The evidence is lacking.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results